Breaking News
Get 55% Off 0
🎈 Up Big Today: Find today's biggest gainers with our free screener
Try Stock Screener
Close

Moderna Inc (MRNA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
850.00 +8.00    +0.95%
12/12 - Closed. Currency in MXN
Type:  Equity
Market:  Mexico
ISIN:  US60770K1079 
  • Volume: 1,788
  • Bid/Ask: 860.00 / 872.00
  • Day's Range: 846.00 - 850.00
Moderna 850.00 +8.00 +0.95%

Moderna Company Profile

 
Explore the Moderna company profile for core details about Moderna, assess Moderna company details, including a description of the company, key contact information, and insights into the top executives. Discover the company's operations and leadership to better understand its role in the industry.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

5600

Equity Type

ORD

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Contact Information

Address 200 Technology Square
Cambridge, 02139
United States
Phone 617 714 6500
Fax 617 649 3910

Top Executives

Name Age Since Title
Noubar B. Afeyan 60 2010 Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board
Stephane Bancel 50 2011 CEO & Director
Melissa J. Moore - 2016 Member of Scientific Advisory Board
Jack W. Szostak - 2014 Chairman of Scientific Advisory Board
Richard C. Willson - 2014 Member of Technology Advisory Board
Fred E. Regnier - 2014 Member of Technology Advisory Board
John G. Aunins 63 2014 Member of Technology Advisory Board
James R. Swartz - 2014 Member of Technology Advisory Board
Elizabeth G. Nabel 72 2021 Independent Director
Elizabeth Edith Tallett 74 2020 Independent Director
Ulrich H. von Andrian-Werburg - - Member of Scientific Advisory Board
Francois Nader 67 2019 Independent Non Executive Director
Robert S. Langer 75 2010 Member of Scientific Advisory Board
Ron Eydelloth - - Member of Scientific Advisory Board
Paul L. Sagan 65 2018 Independent Non Executive Director
Sandra J. Horning 75 2020 Independent Director
Rachel Green - - Member of Scientific Advisory Board
Michael Diamond - - Member of Scientific Advisory Board
Shah Abbas Hussain 59 2024 Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRNA Comments

Write your thoughts about Moderna Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nov 30, 2021 20:11
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great way to punish a stock when being honest
Sharp View
Sharp View Jul 23, 2021 23:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DEVITIYA payale
Sanjeev Agnihotri
Sanjeev Agnihotri Dec 29, 2020 6:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy on dips
hemant borana
hemant borana Jul 03, 2020 2:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why this stock is falling
Pravin Dand
Pravin Dand Jun 16, 2020 19:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
80 is the target phase 3 is completing by july
Jai Hind
Jai Hind Jun 16, 2020 19:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Well done
Jai Hind
Jai Hind Jun 16, 2020 19:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Well done
Jai Hind
Jai Hind Jun 16, 2020 19:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Well done
Pravin Dand
Pravin Dand Jun 15, 2020 20:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buying huge
Pravin Dand
Pravin Dand Jun 15, 2020 19:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they have cleared 2 phase and Huge potential and they have reached at test 3rd. very close buy without having any fear
Pravin Dand
Pravin Dand Jun 15, 2020 19:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
70 is the target
Dixit Patel
Dixit Patel May 21, 2020 0:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yes true
Mayank Verma
Mayank Verma May 19, 2020 23:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
so now what your view on this company will they be successful to make antidote
Pravin Dand
Pravin Dand May 19, 2020 23:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Huge potential and they have reached at test 3 and previous 2 phases got cleared
Pravin Dand
Pravin Dand May 19, 2020 23:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Huge potential and they have reached at test 3 and
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email